rs869312821
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_002074.5(GNB1):c.227A>G(p.Asp76Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D76E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002074.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNB1 | NM_002074.5 | c.227A>G | p.Asp76Gly | missense_variant | 6/12 | ENST00000378609.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNB1 | ENST00000378609.9 | c.227A>G | p.Asp76Gly | missense_variant | 6/12 | 1 | NM_002074.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2021 | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27535533, 27108799) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | This variant disrupts the p.Asp76 amino acid residue in GNB1. Other variant(s) that disrupt this residue have been observed in individuals with GNB1-related conditions (PMID: 27108799), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNB1 protein function. ClinVar contains an entry for this variant (Variation ID: 224711). This missense change has been observed in individual(s) with intellectual disability syndrome (PMID: 27108799). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 76 of the GNB1 protein (p.Asp76Gly). - |
Intellectual disability, autosomal dominant 42 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 02, 2021 | - - |
Acute lymphoid leukemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 02, 2021 | - - |
Hypotonia;C0036572:Seizure;na:Neurodevelopmental Disability Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 05, 2016 | - - |
Hypotonia;C0557874:Global developmental delay;C1860834:Infantile muscular hypotonia;C3714756:Intellectual disability Pathogenic:1
Pathogenic, no assertion criteria provided | research | Genomics And Bioinformatics Analysis Resource, Columbia University | Feb 10, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at